Tablet-based Cognitive Training
Can a Serious Game-based Cognitive Training Attenuate Cognitive Decline Related to Alzheimer's Disease
1 other identifier
interventional
162
1 country
2
Brief Summary
Today the therapy options for dementia due to Alzheimer's disease (AD) are limited. One recommended intervention is cognitive stimulation. We try to develop serious games as a further treatment option, also usable in pre-dementia as well as early stages of dementia and for a long period of time. The main objective of this study is to test, if the computerized-cognitive training (CCT) is able to improve the performance in a score quantifying an "AD-specific" component score. Additionally, the neurobiological effects of the training are investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable alzheimer-disease
Started Jul 2020
Longer than P75 for not_applicable alzheimer-disease
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2020
CompletedFirst Posted
Study publicly available on registry
July 1, 2020
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedJanuary 10, 2025
January 1, 2025
4 years
June 24, 2020
January 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in AD specific component score
The outcome is quantified by an AD component score including measures of EM (auditory verbal learning), SM (verbal fluency, naming task) and spatial abilities (Rey-Osterrieth complex figure test). These scores will be assessed four times, before the training as well as after three, six and nine months by tablet-based cognitive tests. A short follow-up assessment will be performed after a total of 12 months which does not include primary outcome measure.
The primary endpoint will be assessed four times, with breaks of three months in between. Primary outcome will be assessed up to 9 months.
Secondary Outcomes (1)
MRI functional and structural
Secondary endpoints will be assessed two to four times, depending on the study arm, as MRI assessments are not always performed after six and nine months.
Study Arms (3)
Study Intervention
EXPERIMENTALThe study intervention consists of a tablet-based cognitive training, targeting the cognitive domains mostly affected by AD. This training will be performed for three months (each day for 20 minutes). After three months this group will continue the training at home for six months and meet monthly for group sessions (i.e. booster sessions) on site.
Active Control Group
ACTIVE COMPARATORThis control study arm will watch documentaries at home for three months (each day for 20 minutes) , instead of performing the CCT and serve as active control group. This group will also train with the CCT tasks after these three months.
Wait-List Control
OTHERThis control study arm will start with the CCT with a delay of three months and serve as wait-list control group.
Interventions
The study intervention consists of a tablet-based cognitive training, targeting the cognitive domains mostly affected by Alzheimer Disease.
The active control group watches documentaries for three months before starting with the CCT.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of Alzheimer's Disease
- Patients with increased risk for developing dementia
- Must be able to give their consent
You may not qualify if:
- Contra-indications for MRI scanning
- Substance abuse
- Severe medical conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University Hospital of Old Age Psychiatry and Psychotherapy
Bern, 3000, Switzerland
Memory Clinic Zentralschweiz
Lucerne, 6000, Switzerland
Related Publications (1)
Brill E, Krebs C, Falkner M, Peter J, Henke K, Zust M, Minkova L, Brem AK, Kloppel S. Can a serious game-based cognitive training attenuate cognitive decline related to Alzheimer's disease? Protocol for a randomized controlled trial. BMC Psychiatry. 2022 Aug 12;22(1):552. doi: 10.1186/s12888-022-04131-7.
PMID: 35962371BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Klöppel, Prof. Dr.
University of Bern
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2020
First Posted
July 1, 2020
Study Start
July 1, 2020
Primary Completion
July 9, 2024
Study Completion
October 31, 2024
Last Updated
January 10, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- IPD and any additional material will be available when data collection and analysis is completed Items will be retained for the lifetime of the repository (at least 20years)
- Access Criteria
- According to SNF Guidelines IPD will be published in a open access data base
All IPD that underlie results in a publication will be published pseudonymized in a open access data base